Eventide Asset Management - IDEXX LABS INC ownership

IDEXX LABS INC's ticker is IDXX and the CUSIP is 45168D104. A total of 1,048 filers reported holding IDEXX LABS INC in Q2 2023. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.

About IDEXX LABS INC

IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health. The company offers a wide range of products and services to veterinarians, livestock producers, and pet owners worldwide. IDEXX's mission is to enhance the health and well-being of pets, people, and livestock.

IDEXX's core business is in veterinary diagnostics, which includes blood and urine tests, digital imaging, and other diagnostic services. The company's products are used to diagnose and manage a variety of animal diseases, including cancer, heart disease, and infectious diseases.

IDEXX has a strong reputation for innovation and has been recognized for its contributions to the animal health industry. The company has received numerous awards for its products and services, including the Frost & Sullivan Company of the Year Award for Animal Health Diagnostics.

IDEXX has a strong financial position, with a market capitalization of over $30 billion. The company has consistently delivered strong financial results, with revenue growth of over 10% in the most recent quarter.

In conclusion, IDEXX Laboratories, Inc. is a leading provider of diagnostic and information technology solutions for animal health. The company has a strong reputation for innovation and has been recognized for its contributions to the animal health industry. With a strong financial position and consistent revenue growth, IDEXX is well-positioned for continued success in the future.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of IDEXX LABS INC
ValueSharesWeighting
Q3 2023$97,976,465
-18.9%
224,064
-6.9%
1.76%
-13.8%
Q2 2023$120,844,071
-6.3%
240,615
-6.7%
2.04%
-13.7%
Q1 2023$129,019,140
+22.7%
257,997
+0.1%
2.37%
+14.2%
Q4 2022$105,151,282
+25.3%
257,749
+0.1%
2.07%
+25.6%
Q3 2022$83,906,000
-7.0%
257,538
+0.1%
1.65%
-14.5%
Q2 2022$90,243,000
-41.4%
257,300
-8.7%
1.93%
-20.1%
Q1 2022$154,107,000
-16.9%
281,7000.0%2.42%
+1.9%
Q4 2021$185,488,000
+5.9%
281,7000.0%2.37%
+2.6%
Q3 2021$175,189,000
+15.6%
281,700
+17.4%
2.31%
+13.5%
Q2 2021$151,572,000
+29.1%
240,0000.0%2.04%
+17.0%
Q1 2021$117,434,000
-2.1%
240,0000.0%1.74%
-5.4%
Q4 2020$119,969,000
+51.8%
240,000
+19.4%
1.84%
+18.9%
Q3 2020$79,015,000
+36.0%
201,000
+14.2%
1.55%
+22.5%
Q2 2020$58,108,000
+67.7%
176,000
+23.1%
1.26%
+12.6%
Q1 2020$34,640,000
+28.9%
143,000
+39.0%
1.12%
+48.2%
Q4 2019$26,870,000
-4.0%
102,9000.0%0.76%
-18.2%
Q3 2019$27,982,000
-1.2%
102,9000.0%0.92%
+7.4%
Q2 2019$28,331,000102,9000.86%
Other shareholders
IDEXX LABS INC shareholders Q2 2023
NameSharesValueWeighting ↓
CAPITAL COUNSEL LLC/NY 830,476$97,855,0005.50%
AMERICAN CAPITAL MANAGEMENT INC 271,043$31,937,0003.72%
Ruane, Cunniff & Goldfarb 5,197,081$612,372,0003.24%
HARVEY INVESTMENT CO LLC 103,930$12,246,0003.09%
CORTLAND ASSOCIATES INC/MO 97,157$11,448,0002.73%
Biondo Investment Advisors, LLC 63,110$7,436,0002.28%
West Coast Financial LLC 32,246$3,800,0002.14%
Capital Investment Services of America, Inc. 64,823$7,638,0001.94%
HEADINVEST, LLC 34,100$4,831,0001.93%
CARDEROCK CAPITAL MANAGEMENT INC 31,403$3,700,0001.90%
View complete list of IDEXX LABS INC shareholders